awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51146514-D5ED0E2D-AEC9-435C-B825-5DADBDB353A5
Q51146514-D5ED0E2D-AEC9-435C-B825-5DADBDB353A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51146514-D5ED0E2D-AEC9-435C-B825-5DADBDB353A5
Cost-effectiveness of natalizumab in multiple sclerosis.
P2860
Q51146514-D5ED0E2D-AEC9-435C-B825-5DADBDB353A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51146514-D5ED0E2D-AEC9-435C-B825-5DADBDB353A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56bbfba4734fd700839f13a84c72415fe5a82982
P2860
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.